echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Degradation of negative immune regulators enhances immune responses

    Degradation of negative immune regulators enhances immune responses

    • Last Update: 2022-03-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Text: Xiaotong Liu, Yuanyuan Zhou and Dongping Lu Translated by: Yuanlong Liu, TPC Assistant Features Editor The research paper "dependent protein kinase CPK28 is targeted by the ubiquitin ligases ATL31 and ATL6 for proteasome-mediated degradation to fine-tune immune signaling in Arabidopsis" revealed the regulation of innate immunity in Arabidopsis
    .

    Background: Plants rely on innate immunity to defend against microbial pathogens
    .

    When immune receptors recognize microbial molecules, an immune response is triggered
    .

    The cytoplasmic kinase BOTRYTIS-INDUCED KINASE 1 (BIK1) plays an important role in distributing upstream immune signals from different receptors to different substrate proteins
    .

    Homeostasis of BIK1 is tightly controlled and maintained by a regulatory module in which the calcium-dependent protein kinase CPK28 helps maintain BIK1 homeostasis
    .

    Research question: Is CPK28 protein regulated to maintain BIK1 homeostasis while fine-tuning immune signaling? Findings: This study found that CPK28 protein was modified by ubiquitination and subsequently degraded by the 26S proteasome
    .

    Interestingly, bacterial flagellin treatment enhanced the ubiquitination and degradation of CPK28 protein
    .

    Arabidopsis TÓXICOS EN LEVADURA 31 (ATL31) and ATL6, two ubiquitin ligases, directly interact with CPK28 and mediate its ubiquitination, resulting in protein degradation of CPK28 and attenuation of CPK28 function
    .

    Thus, ATL31 and ATL6 regulate BIK1 homeostasis and regulate immune signaling by mediating CPK28 degradation
    .

    This study reveals how CPK28 is controlled to maintain BIK1 homeostasis and enhance immune responses
    .

    Research Outlook: The next research goal is to study how signals are transmitted from immune receptors to ATL31 and ATL6 to mediate the degradation of CPK28
    .

    Original link: https://doi.
    org/10.
    1093/plcell/koab242****Long press the QR code below to identify and follow***
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.